KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 126 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,114,000 | -81.4% | 316,518 | -47.2% | 0.00% | -80.0% |
| Q2 2015 | $5,988,000 | +161.8% | 600,011 | +234.0% | 0.01% | +150.0% |
| Q1 2015 | $2,287,000 | +10295.5% | 179,669 | +11108.3% | 0.00% | – |
| Q3 2014 | $22,000 | -98.8% | 1,603 | -98.7% | 0.00% | -100.0% |
| Q2 2014 | $1,886,000 | -14.8% | 122,654 | -21.4% | 0.00% | -25.0% |
| Q1 2014 | $2,213,000 | -1.2% | 156,082 | +8.0% | 0.00% | 0.0% |
| Q4 2013 | $2,241,000 | +22.7% | 144,565 | -20.1% | 0.00% | +33.3% |
| Q3 2013 | $1,827,000 | +18.3% | 180,924 | -12.5% | 0.00% | 0.0% |
| Q2 2013 | $1,545,000 | – | 206,801 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,312,006 | $22,357,000 | 15.70% |
| VHCP Management, LLC | 1,000,273 | $17,045,000 | 8.86% |
| HARVEY CAPITAL MANAGEMENT INC | 915,800 | $15,605,000 | 6.22% |
| Baupost Group | 6,310,850 | $107,537,000 | 2.60% |
| SECTORAL ASSET MANAGEMENT INC | 3,537,590 | $60,281,000 | 2.48% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 587,504 | $10,011,000 | 2.31% |
| Knoll Capital Management, LLC | 200,000 | $3,408,000 | 1.76% |
| Camber Capital Management LP | 1,250,000 | $21,300,000 | 1.67% |
| NORTHPOINTE CAPITAL LLC | 877,875 | $14,958,000 | 1.52% |
| DAFNA Capital Management LLC | 100,000 | $1,704,000 | 1.46% |